Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    P and L Development of New York Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1DOCOSANOL

    02 3IBUPROFEN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : DOCOSANOL

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow

    Brand Name : DOCOSANOL

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    DOCOSANOL

    P and L Development of New York Corporation

    Dosage Form : CREAM; TOPICAL

    Proprietary Name : DOCOSANOL

    Dosage Strength : 10%

    Approval Date : 2022-10-07

    Application Number : 212385

    RX/OTC/DISCN : OTC

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    IBUPROFEN

    P and L Development of New York Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : IBUPROFEN

    Dosage Strength : 200MG

    Approval Date : 1986-09-19

    Application Number : 70733

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    IBUPROFEN

    P and L Development of New York Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : IBUPROFEN

    Dosage Strength : 200MG

    Approval Date : 2003-11-26

    Application Number : 76460

    RX/OTC/DISCN : OTC

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow

    Brand Name : IBUPROFEN

    U.S.A
    AIChE Annual Meeting
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    IBUPROFEN

    P and L Development of New York Corporation

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : IBUPROFEN

    Dosage Strength : EQ 200MG FREE ACID AND P...

    Approval Date : 2009-07-10

    Application Number : 77338

    RX/OTC/DISCN : OTC

    RLD : No

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place